Germinated brown rice may benefit diabetes patients through catabolism of branched-chain amino acids
China: Germinated brown rice (GBR) intervention in type 2 diabetes mellitus (T2DM) patients was associated with improved biochemical indicators, researchers state in a study published in Molecular Nutrition & Food Research. The underlying mechanism of GBR could be an improvement in insulin resistance and acceleration of BCAAs (branched-chain amino acids) catabolism.
In the GBR group (patients receiving GBR intervention), the study showed a decrease in fasting blood glucose, fasting insulin, and serum BCAAs, and an improvement in islet function.
Adequate consumption of whole grain foods benefits patients with type 2 diabetes. However, there is no clarity on whether preventive effects are related to BCAAs metabolism. Yujuan Shan from Wenzhou Medical University in Wenzhou, Zhejiang, China, and colleagues aimed to assess the impact of GBR intervention on the metabolism of branched-chain amino acids in type 2 diabetes patients in a randomized controlled trial.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.